2025 Fall Guest Speaker: April Risinger, PhD

The research in the Risinger Laboratory is in the area of cancer pharmacology with a focus on microtubule targeted agents and other natural products for the treatment of drug resistant solid tumors. There are three overarching goals of our research, including the identification of biomarkers that can guide a more rational choice among clinically approved microtubule targeted agents for the treatment of women with breast cancer or gynecological malignancies, the development of novel classes of microtubule targeted agents that retain efficacy in drug-resistant disease, and identifying strategies to alleviate the toxicities associated with the use of microtubule-targeted agents and other chemotherapeutics.